aluates Reports

$ 0.0

Automative

Global Sexually Transmitted Diseases Diagnostics Market Research Report 2026

Published Date: 2026-02-13

Report Code: QYRE-Othe-38

Global Sexually Transmitted Diseases Diagnostics Market Research Report 2017

BUY CHAPTERS

Global Sexually Transmitted Diseases Diagnostics Market Research Report 2026

Code: QYRE-Othe-38

Report

2026-02-13

Pages:117

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Hologic Inc

Cepheid Inc

Abbott

Thermo Fisher Scientific

Certest Biotec

Operon

Roche

Bio Rad Laboratories

Qaigen

Diasorin SPA

MedMira

bioMeriuex

Sexually Transmitted Diseases Diagnostics Market Size

The global Sexually Transmitted Diseases Diagnostics market was valued at US$ 4698 million in 2025 and is anticipated to reach US$ 7351 million by 2032, at a CAGR of 6.7% from 2026 to 2032.

Sexually Transmitted Diseases Diagnostics Market

Sexually Transmitted Diseases (STDs) Diagnostics refer to the medical tests and procedures used to detect infections transmitted through sexual contact. These diagnostics encompass a variety of methods, including laboratory tests such as blood tests, urine tests, swabs, and culture tests, as well as rapid diagnostic tests and molecular techniques like polymerase chain reaction (PCR). The purpose of these diagnostics is to identify the presence of pathogens like bacteria, viruses, or parasites responsible for STDs, enabling timely and accurate diagnosis, which is essential for effective treatment and prevention of further transmission.

The North American market for Sexually Transmitted Diseases Diagnostics is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

The Asia-Pacific market for Sexually Transmitted Diseases Diagnostics is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

The global market for Sexually Transmitted Diseases Diagnostics in Gonorrhea is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.

Major global companies of Sexually Transmitted Diseases Diagnostics include Abbott, Thermo Fisher Scientific, CERTEST BIOTEC, OPERON, Roche, Bio-Rad laboratories, Qaigen, Diasorin SPA, MedMira, Hologic, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.

This report delivers a comprehensive overview of the global Sexually Transmitted Diseases Diagnostics market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Sexually Transmitted Diseases Diagnostics. The Sexually Transmitted Diseases Diagnostics market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Sexually Transmitted Diseases Diagnostics market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Sexually Transmitted Diseases Diagnostics manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Sexually Transmitted Diseases Diagnostics Market Report

Report Metric	Details
Report Name	Sexually Transmitted Diseases Diagnostics Market
Accounted market size in 2025	US$ 4698 million
Forecasted market size in 2032	US$ 7351 million
CAGR	6.7%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	Cultural and Isolated Organisms Molecular Test Immunology Assay Other
Segment by Application	Gonorrhea Syphilis Chlamydia Herpes Simplex Virus Human Papillomavirus Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Abbott, Thermo Fisher Scientific, CERTEST BIOTEC, OPERON, Roche, Bio-Rad laboratories, Qaigen, Diasorin SPA, MedMira, Hologic, Cepheid, BioMeriuex
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Sexually Transmitted Diseases Diagnostics companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Sexually Transmitted Diseases Diagnostics Market growing?

Ans: The Sexually Transmitted Diseases Diagnostics Market witnessing a CAGR of 6.7% during the forecast period 2026-2032.

What is the Sexually Transmitted Diseases Diagnostics Market size in 2032?

Ans: The Sexually Transmitted Diseases Diagnostics Market size in 2032 will be US$ 7351 million.

Who are the main players in the Sexually Transmitted Diseases Diagnostics Market report?

Ans: The main players in the Sexually Transmitted Diseases Diagnostics Market are Abbott, Thermo Fisher Scientific, CERTEST BIOTEC, OPERON, Roche, Bio-Rad laboratories, Qaigen, Diasorin SPA, MedMira, Hologic, Cepheid, BioMeriuex

What are the Application segmentation covered in the Sexually Transmitted Diseases Diagnostics Market report?

Ans: The Applications covered in the Sexually Transmitted Diseases Diagnostics Market report are Gonorrhea, Syphilis, Chlamydia, Herpes Simplex Virus, Human Papillomavirus, Others

What are the Type segmentation covered in the Sexually Transmitted Diseases Diagnostics Market report?

Ans: The Types covered in the Sexually Transmitted Diseases Diagnostics Market report are Cultural and Isolated Organisms, Molecular Test, Immunology Assay, Other

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Sexually Transmitted Diseases Diagnostics Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 Cultural and Isolated Organisms

1.2.3 Molecular Test

1.2.4 Immunology Assay

1.2.5 Other

1.3 Market by Application

1.3.1 Global Sexually Transmitted Diseases Diagnostics Market Growth by Application: 2021 vs 2025 vs 2032

1.3.2 Gonorrhea

1.3.3 Syphilis

1.3.4 Chlamydia

1.3.5 Herpes Simplex Virus

1.3.6 Human Papillomavirus

1.3.7 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Sexually Transmitted Diseases Diagnostics Market Perspective (2021–2032)

2.2 Global Sexually Transmitted Diseases Diagnostics Growth Trends by Region

2.2.1 Global Sexually Transmitted Diseases Diagnostics Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Sexually Transmitted Diseases Diagnostics Historic Market Size by Region (2021–2026)

2.2.3 Sexually Transmitted Diseases Diagnostics Forecasted Market Size by Region (2027–2032)

2.3 Sexually Transmitted Diseases Diagnostics Market Dynamics

2.3.1 Sexually Transmitted Diseases Diagnostics Industry Trends

2.3.2 Sexually Transmitted Diseases Diagnostics Market Drivers

2.3.3 Sexually Transmitted Diseases Diagnostics Market Challenges

2.3.4 Sexually Transmitted Diseases Diagnostics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Sexually Transmitted Diseases Diagnostics Players by Revenue

3.1.1 Global Top Sexually Transmitted Diseases Diagnostics Players by Revenue (2021–2026)

3.1.2 Global Sexually Transmitted Diseases Diagnostics Revenue Market Share by Players (2021–2026)

3.2 Global Top Sexually Transmitted Diseases Diagnostics Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Sexually Transmitted Diseases Diagnostics Revenue

3.4 Global Sexually Transmitted Diseases Diagnostics Market Concentration Ratio

3.4.1 Global Sexually Transmitted Diseases Diagnostics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Sexually Transmitted Diseases Diagnostics Revenue in 2025

3.5 Global Key Players of Sexually Transmitted Diseases Diagnostics Head Offices and Areas Served

3.6 Global Key Players of Sexually Transmitted Diseases Diagnostics, Products and Applications

3.7 Global Key Players of Sexually Transmitted Diseases Diagnostics, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 Sexually Transmitted Diseases Diagnostics Breakdown Data by Type

4.1 Global Sexually Transmitted Diseases Diagnostics Historic Market Size by Type (2021–2026)

4.2 Global Sexually Transmitted Diseases Diagnostics Forecasted Market Size by Type (2027–2032)

5 Sexually Transmitted Diseases Diagnostics Breakdown Data by Application

5.1 Global Sexually Transmitted Diseases Diagnostics Historic Market Size by Application (2021–2026)

5.2 Global Sexually Transmitted Diseases Diagnostics Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America Sexually Transmitted Diseases Diagnostics Market Size (2021–2032)

6.2 North America Sexually Transmitted Diseases Diagnostics Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Sexually Transmitted Diseases Diagnostics Market Size by Country (2021–2026)

6.4 North America Sexually Transmitted Diseases Diagnostics Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Sexually Transmitted Diseases Diagnostics Market Size (2021–2032)

7.2 Europe Sexually Transmitted Diseases Diagnostics Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Sexually Transmitted Diseases Diagnostics Market Size by Country (2021–2026)

7.4 Europe Sexually Transmitted Diseases Diagnostics Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Sexually Transmitted Diseases Diagnostics Market Size (2021–2032)

8.2 Asia-Pacific Sexually Transmitted Diseases Diagnostics Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Sexually Transmitted Diseases Diagnostics Market Size by Region (2021–2026)

8.4 Asia-Pacific Sexually Transmitted Diseases Diagnostics Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Sexually Transmitted Diseases Diagnostics Market Size (2021–2032)

9.2 Latin America Sexually Transmitted Diseases Diagnostics Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Sexually Transmitted Diseases Diagnostics Market Size by Country (2021–2026)

9.4 Latin America Sexually Transmitted Diseases Diagnostics Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Sexually Transmitted Diseases Diagnostics Market Size (2021–2032)

10.2 Middle East & Africa Sexually Transmitted Diseases Diagnostics Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Sexually Transmitted Diseases Diagnostics Market Size by Country (2021–2026)

10.4 Middle East & Africa Sexually Transmitted Diseases Diagnostics Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Abbott

11.1.1 Abbott Company Details

11.1.2 Abbott Business Overview

11.1.3 Abbott Sexually Transmitted Diseases Diagnostics Introduction

11.1.4 Abbott Revenue in Sexually Transmitted Diseases Diagnostics Business (2021–2026)

11.1.5 Abbott Recent Development

11.2 Thermo Fisher Scientific

11.2.1 Thermo Fisher Scientific Company Details

11.2.2 Thermo Fisher Scientific Business Overview

11.2.3 Thermo Fisher Scientific Sexually Transmitted Diseases Diagnostics Introduction

11.2.4 Thermo Fisher Scientific Revenue in Sexually Transmitted Diseases Diagnostics Business (2021–2026)

11.2.5 Thermo Fisher Scientific Recent Development

11.3 CERTEST BIOTEC

11.3.1 CERTEST BIOTEC Company Details

11.3.2 CERTEST BIOTEC Business Overview

11.3.3 CERTEST BIOTEC Sexually Transmitted Diseases Diagnostics Introduction

11.3.4 CERTEST BIOTEC Revenue in Sexually Transmitted Diseases Diagnostics Business (2021–2026)

11.3.5 CERTEST BIOTEC Recent Development

11.4 OPERON

11.4.1 OPERON Company Details

11.4.2 OPERON Business Overview

11.4.3 OPERON Sexually Transmitted Diseases Diagnostics Introduction

11.4.4 OPERON Revenue in Sexually Transmitted Diseases Diagnostics Business (2021–2026)

11.4.5 OPERON Recent Development

11.5 Roche

11.5.1 Roche Company Details

11.5.2 Roche Business Overview

11.5.3 Roche Sexually Transmitted Diseases Diagnostics Introduction

11.5.4 Roche Revenue in Sexually Transmitted Diseases Diagnostics Business (2021–2026)

11.5.5 Roche Recent Development

11.6 Bio-Rad laboratories

11.6.1 Bio-Rad laboratories Company Details

11.6.2 Bio-Rad laboratories Business Overview

11.6.3 Bio-Rad laboratories Sexually Transmitted Diseases Diagnostics Introduction

11.6.4 Bio-Rad laboratories Revenue in Sexually Transmitted Diseases Diagnostics Business (2021–2026)

11.6.5 Bio-Rad laboratories Recent Development

11.7 Qaigen

11.7.1 Qaigen Company Details

11.7.2 Qaigen Business Overview

11.7.3 Qaigen Sexually Transmitted Diseases Diagnostics Introduction

11.7.4 Qaigen Revenue in Sexually Transmitted Diseases Diagnostics Business (2021–2026)

11.7.5 Qaigen Recent Development

11.8 Diasorin SPA

11.8.1 Diasorin SPA Company Details

11.8.2 Diasorin SPA Business Overview

11.8.3 Diasorin SPA Sexually Transmitted Diseases Diagnostics Introduction

11.8.4 Diasorin SPA Revenue in Sexually Transmitted Diseases Diagnostics Business (2021–2026)

11.8.5 Diasorin SPA Recent Development

11.9 MedMira

11.9.1 MedMira Company Details

11.9.2 MedMira Business Overview

11.9.3 MedMira Sexually Transmitted Diseases Diagnostics Introduction

11.9.4 MedMira Revenue in Sexually Transmitted Diseases Diagnostics Business (2021–2026)

11.9.5 MedMira Recent Development

11.10 Hologic

11.10.1 Hologic Company Details

11.10.2 Hologic Business Overview

11.10.3 Hologic Sexually Transmitted Diseases Diagnostics Introduction

11.10.4 Hologic Revenue in Sexually Transmitted Diseases Diagnostics Business (2021–2026)

11.10.5 Hologic Recent Development

11.11 Cepheid

11.11.1 Cepheid Company Details

11.11.2 Cepheid Business Overview

11.11.3 Cepheid Sexually Transmitted Diseases Diagnostics Introduction

11.11.4 Cepheid Revenue in Sexually Transmitted Diseases Diagnostics Business (2021–2026)

11.11.5 Cepheid Recent Development

11.12 BioMeriuex

11.12.1 BioMeriuex Company Details

11.12.2 BioMeriuex Business Overview

11.12.3 BioMeriuex Sexually Transmitted Diseases Diagnostics Introduction

11.12.4 BioMeriuex Revenue in Sexually Transmitted Diseases Diagnostics Business (2021–2026)

11.12.5 BioMeriuex Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Hologic Inc

Cepheid Inc

Abbott

Thermo Fisher Scientific

Certest Biotec

Operon

Roche

Bio Rad Laboratories

Qaigen

Diasorin SPA

MedMira

bioMeriuex

List of Tables

Table 1. Global Sexually Transmitted Diseases Diagnostics Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of Cultural and Isolated Organisms

Table 3. Key Players of Molecular Test

Table 4. Key Players of Immunology Assay

Table 5. Key Players of Other

Table 6. Global Sexually Transmitted Diseases Diagnostics Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 7. Global Sexually Transmitted Diseases Diagnostics Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 8. Global Sexually Transmitted Diseases Diagnostics Market Size by Region (US$ Million), 2021–2026

Table 9. Global Sexually Transmitted Diseases Diagnostics Market Share by Region (2021–2026)

Table 10. Global Sexually Transmitted Diseases Diagnostics Forecasted Market Size by Region (US$ Million), 2027–2032

Table 11. Global Sexually Transmitted Diseases Diagnostics Market Share by Region (2027–2032)

Table 12. Sexually Transmitted Diseases Diagnostics Market Trends

Table 13. Sexually Transmitted Diseases Diagnostics Market Drivers

Table 14. Sexually Transmitted Diseases Diagnostics Market Challenges

Table 15. Sexually Transmitted Diseases Diagnostics Market Restraints

Table 16. Global Sexually Transmitted Diseases Diagnostics Revenue by Players (US$ Million), 2021–2026

Table 17. Global Sexually Transmitted Diseases Diagnostics Market Share by Players (2021–2026)

Table 18. Global Top Sexually Transmitted Diseases Diagnostics Players by Tier (Tier 1, Tier 2, and Tier 3), based on Sexually Transmitted Diseases Diagnostics Revenue, 2025

Table 19. Ranking of Global Top Sexually Transmitted Diseases Diagnostics Companies by Revenue (US$ Million) in 2025

Table 20. Global 5 Largest Players Market Share by Sexually Transmitted Diseases Diagnostics Revenue (CR5 and HHI), 2021–2026

Table 21. Global Key Players of Sexually Transmitted Diseases Diagnostics, Headquarters and Area Served

Table 22. Global Key Players of Sexually Transmitted Diseases Diagnostics, Products and Applications

Table 23. Global Key Players of Sexually Transmitted Diseases Diagnostics, Date of General Availability (GA)

Table 24. Mergers and Acquisitions, Expansion Plans

Table 25. Global Sexually Transmitted Diseases Diagnostics Market Size by Type (US$ Million), 2021–2026

Table 26. Global Sexually Transmitted Diseases Diagnostics Revenue Market Share by Type (2021–2026)

Table 27. Global Sexually Transmitted Diseases Diagnostics Forecasted Market Size by Type (US$ Million), 2027–2032

Table 28. Global Sexually Transmitted Diseases Diagnostics Revenue Market Share by Type (2027–2032)

Table 29. Global Sexually Transmitted Diseases Diagnostics Market Size by Application (US$ Million), 2021–2026

Table 30. Global Sexually Transmitted Diseases Diagnostics Revenue Market Share by Application (2021–2026)

Table 31. Global Sexually Transmitted Diseases Diagnostics Forecasted Market Size by Application (US$ Million), 2027–2032

Table 32. Global Sexually Transmitted Diseases Diagnostics Revenue Market Share by Application (2027–2032)

Table 33. North America Sexually Transmitted Diseases Diagnostics Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 34. North America Sexually Transmitted Diseases Diagnostics Market Size by Country (US$ Million), 2021–2026

Table 35. North America Sexually Transmitted Diseases Diagnostics Market Size by Country (US$ Million), 2027–2032

Table 36. Europe Sexually Transmitted Diseases Diagnostics Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 37. Europe Sexually Transmitted Diseases Diagnostics Market Size by Country (US$ Million), 2021–2026

Table 38. Europe Sexually Transmitted Diseases Diagnostics Market Size by Country (US$ Million), 2027–2032

Table 39. Asia-Pacific Sexually Transmitted Diseases Diagnostics Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 40. Asia-Pacific Sexually Transmitted Diseases Diagnostics Market Size by Region (US$ Million), 2021–2026

Table 41. Asia-Pacific Sexually Transmitted Diseases Diagnostics Market Size by Region (US$ Million), 2027–2032

Table 42. Latin America Sexually Transmitted Diseases Diagnostics Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 43. Latin America Sexually Transmitted Diseases Diagnostics Market Size by Country (US$ Million), 2021–2026

Table 44. Latin America Sexually Transmitted Diseases Diagnostics Market Size by Country (US$ Million), 2027–2032

Table 45. Middle East & Africa Sexually Transmitted Diseases Diagnostics Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 46. Middle East & Africa Sexually Transmitted Diseases Diagnostics Market Size by Country (US$ Million), 2021–2026

Table 47. Middle East & Africa Sexually Transmitted Diseases Diagnostics Market Size by Country (US$ Million), 2027–2032

Table 48. Abbott Company Details

Table 49. Abbott Business Overview

Table 50. Abbott Sexually Transmitted Diseases Diagnostics Product

Table 51. Abbott Revenue in Sexually Transmitted Diseases Diagnostics Business (US$ Million), 2021–2026

Table 52. Abbott Recent Development

Table 53. Thermo Fisher Scientific Company Details

Table 54. Thermo Fisher Scientific Business Overview

Table 55. Thermo Fisher Scientific Sexually Transmitted Diseases Diagnostics Product

Table 56. Thermo Fisher Scientific Revenue in Sexually Transmitted Diseases Diagnostics Business (US$ Million), 2021–2026

Table 57. Thermo Fisher Scientific Recent Development

Table 58. CERTEST BIOTEC Company Details

Table 59. CERTEST BIOTEC Business Overview

Table 60. CERTEST BIOTEC Sexually Transmitted Diseases Diagnostics Product

Table 61. CERTEST BIOTEC Revenue in Sexually Transmitted Diseases Diagnostics Business (US$ Million), 2021–2026

Table 62. CERTEST BIOTEC Recent Development

Table 63. OPERON Company Details

Table 64. OPERON Business Overview

Table 65. OPERON Sexually Transmitted Diseases Diagnostics Product

Table 66. OPERON Revenue in Sexually Transmitted Diseases Diagnostics Business (US$ Million), 2021–2026

Table 67. OPERON Recent Development

Table 68. Roche Company Details

Table 69. Roche Business Overview

Table 70. Roche Sexually Transmitted Diseases Diagnostics Product

Table 71. Roche Revenue in Sexually Transmitted Diseases Diagnostics Business (US$ Million), 2021–2026

Table 72. Roche Recent Development

Table 73. Bio-Rad laboratories Company Details

Table 74. Bio-Rad laboratories Business Overview

Table 75. Bio-Rad laboratories Sexually Transmitted Diseases Diagnostics Product

Table 76. Bio-Rad laboratories Revenue in Sexually Transmitted Diseases Diagnostics Business (US$ Million), 2021–2026

Table 77. Bio-Rad laboratories Recent Development

Table 78. Qaigen Company Details

Table 79. Qaigen Business Overview

Table 80. Qaigen Sexually Transmitted Diseases Diagnostics Product

Table 81. Qaigen Revenue in Sexually Transmitted Diseases Diagnostics Business (US$ Million), 2021–2026

Table 82. Qaigen Recent Development

Table 83. Diasorin SPA Company Details

Table 84. Diasorin SPA Business Overview

Table 85. Diasorin SPA Sexually Transmitted Diseases Diagnostics Product

Table 86. Diasorin SPA Revenue in Sexually Transmitted Diseases Diagnostics Business (US$ Million), 2021–2026

Table 87. Diasorin SPA Recent Development

Table 88. MedMira Company Details

Table 89. MedMira Business Overview

Table 90. MedMira Sexually Transmitted Diseases Diagnostics Product

Table 91. MedMira Revenue in Sexually Transmitted Diseases Diagnostics Business (US$ Million), 2021–2026

Table 92. MedMira Recent Development

Table 93. Hologic Company Details

Table 94. Hologic Business Overview

Table 95. Hologic Sexually Transmitted Diseases Diagnostics Product

Table 96. Hologic Revenue in Sexually Transmitted Diseases Diagnostics Business (US$ Million), 2021–2026

Table 97. Hologic Recent Development

Table 98. Cepheid Company Details

Table 99. Cepheid Business Overview

Table 100. Cepheid Sexually Transmitted Diseases Diagnostics Product

Table 101. Cepheid Revenue in Sexually Transmitted Diseases Diagnostics Business (US$ Million), 2021–2026

Table 102. Cepheid Recent Development

Table 103. BioMeriuex Company Details

Table 104. BioMeriuex Business Overview

Table 105. BioMeriuex Sexually Transmitted Diseases Diagnostics Product

Table 106. BioMeriuex Revenue in Sexually Transmitted Diseases Diagnostics Business (US$ Million), 2021–2026

Table 107. BioMeriuex Recent Development

Table 108. Research Programs/Design for This Report

Table 109. Key Data Information from Secondary Sources

Table 110. Key Data Information from Primary Sources

Table 111. Authors List of This Report

List of Figures

Figure 1. Sexually Transmitted Diseases Diagnostics Picture

Figure 2. Global Sexually Transmitted Diseases Diagnostics Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global Sexually Transmitted Diseases Diagnostics Market Share by Type: 2025 vs 2032

Figure 4. Cultural and Isolated Organisms Features

Figure 5. Molecular Test Features

Figure 6. Immunology Assay Features

Figure 7. Other Features

Figure 8. Global Sexually Transmitted Diseases Diagnostics Market Size by Application (US$ Million), 2021–2032

Figure 9. Global Sexually Transmitted Diseases Diagnostics Market Share by Application: 2025 vs 2032

Figure 10. Gonorrhea Case Studies

Figure 11. Syphilis Case Studies

Figure 12. Chlamydia Case Studies

Figure 13. Herpes Simplex Virus Case Studies

Figure 14. Human Papillomavirus Case Studies

Figure 15. Others Case Studies

Figure 16. Sexually Transmitted Diseases Diagnostics Report Years Considered

Figure 17. Global Sexually Transmitted Diseases Diagnostics Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 18. Global Sexually Transmitted Diseases Diagnostics Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 19. Global Sexually Transmitted Diseases Diagnostics Market Share by Region: 2025 vs 2032

Figure 20. Global Sexually Transmitted Diseases Diagnostics Market Share by Players in 2025

Figure 21. Global Sexually Transmitted Diseases Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 22. The Top 10 and 5 Players Market Share by Sexually Transmitted Diseases Diagnostics Revenue in 2025

Figure 23. North America Sexually Transmitted Diseases Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 24. North America Sexually Transmitted Diseases Diagnostics Market Share by Country (2021–2032)

Figure 25. United States Sexually Transmitted Diseases Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 26. Canada Sexually Transmitted Diseases Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 27. Europe Sexually Transmitted Diseases Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 28. Europe Sexually Transmitted Diseases Diagnostics Market Share by Country (2021–2032)

Figure 29. Germany Sexually Transmitted Diseases Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 30. France Sexually Transmitted Diseases Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 31. U.K. Sexually Transmitted Diseases Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 32. Italy Sexually Transmitted Diseases Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 33. Russia Sexually Transmitted Diseases Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 34. Ireland Sexually Transmitted Diseases Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 35. Asia-Pacific Sexually Transmitted Diseases Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 36. Asia-Pacific Sexually Transmitted Diseases Diagnostics Market Share by Region (2021–2032)

Figure 37. China Sexually Transmitted Diseases Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. Japan Sexually Transmitted Diseases Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 39. South Korea Sexually Transmitted Diseases Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 40. Southeast Asia Sexually Transmitted Diseases Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 41. India Sexually Transmitted Diseases Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 42. Australia & New Zealand Sexually Transmitted Diseases Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 43. Latin America Sexually Transmitted Diseases Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 44. Latin America Sexually Transmitted Diseases Diagnostics Market Share by Country (2021–2032)

Figure 45. Mexico Sexually Transmitted Diseases Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 46. Brazil Sexually Transmitted Diseases Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 47. Middle East & Africa Sexually Transmitted Diseases Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 48. Middle East & Africa Sexually Transmitted Diseases Diagnostics Market Share by Country (2021–2032)

Figure 49. Israel Sexually Transmitted Diseases Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 50. Saudi Arabia Sexually Transmitted Diseases Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 51. UAE Sexually Transmitted Diseases Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 52. Abbott Revenue Growth Rate in Sexually Transmitted Diseases Diagnostics Business (2021–2026)

Figure 53. Thermo Fisher Scientific Revenue Growth Rate in Sexually Transmitted Diseases Diagnostics Business (2021–2026)

Figure 54. CERTEST BIOTEC Revenue Growth Rate in Sexually Transmitted Diseases Diagnostics Business (2021–2026)

Figure 55. OPERON Revenue Growth Rate in Sexually Transmitted Diseases Diagnostics Business (2021–2026)

Figure 56. Roche Revenue Growth Rate in Sexually Transmitted Diseases Diagnostics Business (2021–2026)

Figure 57. Bio-Rad laboratories Revenue Growth Rate in Sexually Transmitted Diseases Diagnostics Business (2021–2026)

Figure 58. Qaigen Revenue Growth Rate in Sexually Transmitted Diseases Diagnostics Business (2021–2026)

Figure 59. Diasorin SPA Revenue Growth Rate in Sexually Transmitted Diseases Diagnostics Business (2021–2026)

Figure 60. MedMira Revenue Growth Rate in Sexually Transmitted Diseases Diagnostics Business (2021–2026)

Figure 61. Hologic Revenue Growth Rate in Sexually Transmitted Diseases Diagnostics Business (2021–2026)

Figure 62. Cepheid Revenue Growth Rate in Sexually Transmitted Diseases Diagnostics Business (2021–2026)

Figure 63. BioMeriuex Revenue Growth Rate in Sexually Transmitted Diseases Diagnostics Business (2021–2026)

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Sexually Transmitted Disease Testing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Diagnostic Testing For STDs Market Insights Forecast to 2030

STD Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global STD Rapid Antibody Test Market Research Report 2025

Global Sexually Transmitted Disease STD Testing Market Insights Forecast to 2030

Global Sexually Transmitted Diseases STD Testing Market Insights Forecast to 2030

Global Std Self Diagnostics Market Research Report 2024

STDs Diagnosis Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Sexually Transmitted Diseases Testing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Sexually Transmitted Diseases STD Diagnostics Market Research Report 2024

Molecular Diagnostics Infectious Disease Testing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Molecular Diagnostics in Infectious Disease Testing Market Research Report 2024

Global Chlamydia Infection Test Market Research Report 2024

Global STD Rapid Detection Kit Market Research Report 2025

Global STD Rapid Test Kits Market Insights Forecast to 2030

Global Chlamydia Trachomatis Test Kit Market Research Report 2025

Global Gonorrhea Rapid Test Kit Market Research Report 2025

Global In Vitro Testing for Infectious Diseases Market Research Report 2024

Global Molecular Infectious Disease Testing Market Research Report 2025

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions